GlassScriptPhysician profile
David Dicaprio
NPI 1578806147
$1,165.92
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.74 · 2021: $123 · 2022: $129 · 2023: $865 · 2024: $23.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $431.88 | 2022-2023 | Xifaxan, Trulance, Uceris |
| Celgene Corporation | $221.93 | 2022-2024 | Zeposia |
| Ferring Pharmaceuticals INC. | $99.91 | 2021-2023 | Rebyota, Clenpiq |
| Amgen INC. | $95.26 | 2023 | Amjevita, Avsola |
| Takeda Pharmaceuticals U.S.A., INC. | $73.88 | 2021-2022 | |
| Micro-Tech Endoscopy USA, INC. | $67.48 | 2021-2024 | Clips (Need Marketed Device Name), Lesion Hunter, Edgehog |
| Braintree Laboratories, INC. | $66.05 | 2023 | Sutab, Suflave |
| Abbvie INC. | $55.07 | 2021-2023 | Linzess, Viberzi |
| Qol Medical, LLC | $29.72 | 2022 | |
| Shire North American Group INC | $24.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dicaprio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.